Image Diagnostics
Generated 5/9/2026
Executive Summary
Image Diagnostics Inc. (IDI) is a veteran-owned manufacturer specializing in C-Arm compatible imaging tables and radiation shielding products for surgical and imaging applications, including urology, vascular, hybrid, and GI procedures. Based in San Francisco, the company also offers mobile video integration solutions. Since its founding in 2015, IDI has focused on niche medical imaging hardware and accessories, leveraging AI/ML to enhance diagnostic workflows. While the company operates in the growing medical imaging market, its small scale and lack of disclosed funding or revenue data suggest a conservative growth trajectory. IDI's veteran ownership may provide advantages in government contracts, but its limited public profile and absence of pipeline details constrain visibility into near-term prospects. The company faces competition from larger medical device firms, yet its specialized product line could capture specific segments. With no recent milestones or financial disclosures, IDI appears to be a stable but low-growth entity in the diagnostics space.
Upcoming Catalysts (preview)
- Q4 2026FDA Clearance for Next-Generation Imaging Table40% success
- Q2 2027Partnership with Major Hospital System for C-Arm Tables50% success
- TBDLaunch of AI-Integrated Shielding Product Line30% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)